Compare ECL & MDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ECL | MDT |
|---|---|---|
| Founded | 1923 | 1949 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Package Goods/Cosmetics | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 77.5B | 131.9B |
| IPO Year | 2007 | 2014 |
| Metric | ECL | MDT |
|---|---|---|
| Price | $277.11 | $89.05 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 16 | 19 |
| Target Price | ★ $317.40 | $109.82 |
| AVG Volume (30 Days) | 1.2M | ★ 7.8M |
| Earning Date | 05-18-2026 | 01-01-0001 |
| Dividend Yield | 1.05% | ★ 3.19% |
| EPS Growth | N/A | ★ 30.80 |
| EPS | ★ 7.28 | 2.76 |
| Revenue | $16,081,200,000.00 | ★ $33,537,000,000.00 |
| Revenue This Year | $8.56 | $8.91 |
| Revenue Next Year | $4.84 | $6.75 |
| P/E Ratio | $38.01 | ★ $32.23 |
| Revenue Growth | 2.16 | ★ 3.62 |
| 52 Week Low | $229.39 | $79.55 |
| 52 Week High | $309.27 | $106.33 |
| Indicator | ECL | MDT |
|---|---|---|
| Relative Strength Index (RSI) | 30.33 | 25.36 |
| Support Level | $254.75 | $88.29 |
| Resistance Level | $279.91 | $93.13 |
| Average True Range (ATR) | 5.77 | 1.83 |
| MACD | -4.04 | -0.88 |
| Stochastic Oscillator | 5.68 | 8.79 |
Ecolab produces and markets cleaning and sanitation products for the industrial manufacturing, hospitality, healthcare, and life sciences markets. The firm is the global market share leader in this category with a wide array of products and services, including dish and laundry washing systems, pest control, and infection control products. Additionally, Ecolab sells customized water management solutions across its end markets. The company has a strong hold on the US market and is growing its presence abroad.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, transcatheter heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, ablation laser therapy, and surgical tools. The company primarily markets its products to healthcare institutions and physicians in the United States, Western Europe, and Japan. Foreign sales account for roughly 50% of the company's total sales.